The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

EU, AstraZeneca fail to make breakthrough on vaccine deliveries, EU says

Wed, 27th Jan 2021 20:24

BRUSSELS, Jan 27 (Reuters) - The European Union and
AstraZeneca failed to make a breakthrough on Wednesday
over delayed COVID-19 vaccine deliveries, the bloc's health
chief said.

The EU is pushing the company to supply more doses of its
vaccine from plants in Europe and Britain after the AstraZeneca
announced delivery delays, adding to frustrations over the EU's
inoculation programme.

"We regret the continued lack of clarity on the delivery
schedule," EU Health Commissioner Stella Kyriakides said in a
tweet, adding the EU was requesting a clear plan from
AstraZeneca for the rapid delivery of the vaccine doses the bloc
has reserved for the first quarter.
(Reporting by Sabine Siebold; editing by Philip Blenkinsop)

Related Shares

More News
Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.